Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Supreme Court refuses to stop Zydus from marketing its cancer drug biosimilar, advises Bristol Myers to seek relief from High Court.

11 Feb, 2026

In Response to Talent Shortage, Radiopharma Sector Expands Recruitment Efforts - BioSpace

10 Feb, 2026

BMY Rises 7.6% After Q4 Earnings Report: Is It Time to Buy, Sell, or Hold?

09 Feb, 2026

Bristol Myers Squibb's confidence in an old medication's potential for Alzheimer's treatment - STAT News

02 Feb, 2026

See More